Global Blood Pressure Disorders Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026


  • Mar 2021
  • |
  • 156
  • |
  • Pharmaceuticals and Healthcare

The Blood Pressure Disorders Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Blood Pressure Disorders Drug size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Blood Pressure Disorders Drug market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Blood Pressure Disorders Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Diuretics

Angiotensin Converting Enzyme (ACE) Inhibitors

Angiotensin Receptor Blockers (ARBs)

Others

Market segment by Application, can be divided into

Hypertension

Hypotension

Pulmonary Hypertension

Market segment by players, this report covers

A1M Pharma AB

Acceleron Pharma Inc

Ache Laboratorios Farmaceuticos SA

Actelion Pharmaceuticals Ltd

Aerogen Ltd

Anavex Life Sciences Corp

AnGes Inc

Arena Pharmaceuticals Inc

Ascendia Pharmaceuticals LLC

Ascendis Pharma A/S

AVEO Pharmaceuticals Inc

Bayer AG

Bial - Portela & Ca SA

Bioblue Technologies Inc

Biogen Inc

Biolab Farmaceutica Ltda

BioRestorative Therapies Inc

Boryung Pharmaceutical Co Ltd

Bristol-Myers Squibb Co

Camurus AB

Capricor Therapeutics Inc

Celsion Corp

Celtaxsys Inc

Chiesi Farmaceutici SpA

Chong Kun Dang Pharmaceutical Corp

Chugai Pharmaceutical Co Ltd

CJ HealthCare Corp

Complexa Inc

Corion Biotech Srl

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Blood Pressure Disorders Drug

1.2 Classification of Blood Pressure Disorders Drug by Type

1.2.1 Overview: Global Blood Pressure Disorders Drug Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Blood Pressure Disorders Drug Revenue Market Share by Type in 2020

1.2.3 Diuretics

1.2.4 Angiotensin Converting Enzyme (ACE) Inhibitors

1.2.5 Angiotensin Receptor Blockers (ARBs)

1.2.6 Others

1.3 Global Blood Pressure Disorders Drug Market by Application

1.3.1 Overview: Global Blood Pressure Disorders Drug Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hypertension

1.3.3 Hypotension

1.3.4 Pulmonary Hypertension

1.4 Global Blood Pressure Disorders Drug Market Size & Forecast

1.5 Global Blood Pressure Disorders Drug Market Size and Forecast by Region

1.5.1 Global Blood Pressure Disorders Drug Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Blood Pressure Disorders Drug Market Size by Region, (2016-2021)

1.5.3 North America Blood Pressure Disorders Drug Market Size and Prospect (2016-2026)

1.5.4 Europe Blood Pressure Disorders Drug Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Blood Pressure Disorders Drug Market Size and Prospect (2016-2026)

1.5.6 South America Blood Pressure Disorders Drug Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Blood Pressure Disorders Drug Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Blood Pressure Disorders Drug Market Drivers

1.6.2 Blood Pressure Disorders Drug Market Restraints

1.6.3 Blood Pressure Disorders Drug Trends Analysis

2 Company Profiles

2.1 A1M Pharma AB

2.1.1 A1M Pharma AB Details

2.1.2 A1M Pharma AB Major Business

2.1.3 A1M Pharma AB Blood Pressure Disorders Drug Product and Solutions

2.1.4 A1M Pharma AB Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 A1M Pharma AB Recent Developments and Future Plans

2.2 Acceleron Pharma Inc

2.2.1 Acceleron Pharma Inc Details

2.2.2 Acceleron Pharma Inc Major Business

2.2.3 Acceleron Pharma Inc Blood Pressure Disorders Drug Product and Solutions

2.2.4 Acceleron Pharma Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Acceleron Pharma Inc Recent Developments and Future Plans

2.3 Ache Laboratorios Farmaceuticos SA

2.3.1 Ache Laboratorios Farmaceuticos SA Details

2.3.2 Ache Laboratorios Farmaceuticos SA Major Business

2.3.3 Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Product and Solutions

2.3.4 Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Ache Laboratorios Farmaceuticos SA Recent Developments and Future Plans

2.4 Actelion Pharmaceuticals Ltd

2.4.1 Actelion Pharmaceuticals Ltd Details

2.4.2 Actelion Pharmaceuticals Ltd Major Business

2.4.3 Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Product and Solutions

2.4.4 Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Actelion Pharmaceuticals Ltd Recent Developments and Future Plans

2.5 Aerogen Ltd

2.5.1 Aerogen Ltd Details

2.5.2 Aerogen Ltd Major Business

2.5.3 Aerogen Ltd Blood Pressure Disorders Drug Product and Solutions

2.5.4 Aerogen Ltd Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Aerogen Ltd Recent Developments and Future Plans

2.6 Anavex Life Sciences Corp

2.6.1 Anavex Life Sciences Corp Details

2.6.2 Anavex Life Sciences Corp Major Business

2.6.3 Anavex Life Sciences Corp Blood Pressure Disorders Drug Product and Solutions

2.6.4 Anavex Life Sciences Corp Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Anavex Life Sciences Corp Recent Developments and Future Plans

2.7 AnGes Inc

2.7.1 AnGes Inc Details

2.7.2 AnGes Inc Major Business

2.7.3 AnGes Inc Blood Pressure Disorders Drug Product and Solutions

2.7.4 AnGes Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 AnGes Inc Recent Developments and Future Plans

2.8 Arena Pharmaceuticals Inc

2.8.1 Arena Pharmaceuticals Inc Details

2.8.2 Arena Pharmaceuticals Inc Major Business

2.8.3 Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Product and Solutions

2.8.4 Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Arena Pharmaceuticals Inc Recent Developments and Future Plans

2.9 Ascendia Pharmaceuticals LLC

2.9.1 Ascendia Pharmaceuticals LLC Details

2.9.2 Ascendia Pharmaceuticals LLC Major Business

2.9.3 Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Product and Solutions

2.9.4 Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Ascendia Pharmaceuticals LLC Recent Developments and Future Plans

2.10 Ascendis Pharma A/S

2.10.1 Ascendis Pharma A/S Details

2.10.2 Ascendis Pharma A/S Major Business

2.10.3 Ascendis Pharma A/S Blood Pressure Disorders Drug Product and Solutions

2.10.4 Ascendis Pharma A/S Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Ascendis Pharma A/S Recent Developments and Future Plans

2.11 AVEO Pharmaceuticals Inc

2.11.1 AVEO Pharmaceuticals Inc Details

2.11.2 AVEO Pharmaceuticals Inc Major Business

2.11.3 AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Product and Solutions

2.11.4 AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 AVEO Pharmaceuticals Inc Recent Developments and Future Plans

2.12 Bayer AG

2.12.1 Bayer AG Details

2.12.2 Bayer AG Major Business

2.12.3 Bayer AG Blood Pressure Disorders Drug Product and Solutions

2.12.4 Bayer AG Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Bayer AG Recent Developments and Future Plans

2.13 Bial - Portela & Ca SA

2.13.1 Bial - Portela & Ca SA Details

2.13.2 Bial - Portela & Ca SA Major Business

2.13.3 Bial - Portela & Ca SA Blood Pressure Disorders Drug Product and Solutions

2.13.4 Bial - Portela & Ca SA Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Bial - Portela & Ca SA Recent Developments and Future Plans

2.14 Bioblue Technologies Inc

2.14.1 Bioblue Technologies Inc Details

2.14.2 Bioblue Technologies Inc Major Business

2.14.3 Bioblue Technologies Inc Blood Pressure Disorders Drug Product and Solutions

2.14.4 Bioblue Technologies Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Bioblue Technologies Inc Recent Developments and Future Plans

2.15 Biogen Inc

2.15.1 Biogen Inc Details

2.15.2 Biogen Inc Major Business

2.15.3 Biogen Inc Blood Pressure Disorders Drug Product and Solutions

2.15.4 Biogen Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Biogen Inc Recent Developments and Future Plans

2.16 Biolab Farmaceutica Ltda

2.16.1 Biolab Farmaceutica Ltda Details

2.16.2 Biolab Farmaceutica Ltda Major Business

2.16.3 Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Product and Solutions

2.16.4 Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Biolab Farmaceutica Ltda Recent Developments and Future Plans

2.17 BioRestorative Therapies Inc

2.17.1 BioRestorative Therapies Inc Details

2.17.2 BioRestorative Therapies Inc Major Business

2.17.3 BioRestorative Therapies Inc Blood Pressure Disorders Drug Product and Solutions

2.17.4 BioRestorative Therapies Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 BioRestorative Therapies Inc Recent Developments and Future Plans

2.18 Boryung Pharmaceutical Co Ltd

2.18.1 Boryung Pharmaceutical Co Ltd Details

2.18.2 Boryung Pharmaceutical Co Ltd Major Business

2.18.3 Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Product and Solutions

2.18.4 Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Boryung Pharmaceutical Co Ltd Recent Developments and Future Plans

2.19 Bristol-Myers Squibb Co

2.19.1 Bristol-Myers Squibb Co Details

2.19.2 Bristol-Myers Squibb Co Major Business

2.19.3 Bristol-Myers Squibb Co Blood Pressure Disorders Drug Product and Solutions

2.19.4 Bristol-Myers Squibb Co Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Bristol-Myers Squibb Co Recent Developments and Future Plans

2.20 Camurus AB

2.20.1 Camurus AB Details

2.20.2 Camurus AB Major Business

2.20.3 Camurus AB Blood Pressure Disorders Drug Product and Solutions

2.20.4 Camurus AB Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 Camurus AB Recent Developments and Future Plans

2.21 Capricor Therapeutics Inc

2.21.1 Capricor Therapeutics Inc Details

2.21.2 Capricor Therapeutics Inc Major Business

2.21.3 Capricor Therapeutics Inc Blood Pressure Disorders Drug Product and Solutions

2.21.4 Capricor Therapeutics Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.21.5 Capricor Therapeutics Inc Recent Developments and Future Plans

2.22 Celsion Corp

2.22.1 Celsion Corp Details

2.22.2 Celsion Corp Major Business

2.22.3 Celsion Corp Blood Pressure Disorders Drug Product and Solutions

2.22.4 Celsion Corp Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.22.5 Celsion Corp Recent Developments and Future Plans

2.23 Celtaxsys Inc

2.23.1 Celtaxsys Inc Details

2.23.2 Celtaxsys Inc Major Business

2.23.3 Celtaxsys Inc Blood Pressure Disorders Drug Product and Solutions

2.23.4 Celtaxsys Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.23.5 Celtaxsys Inc Recent Developments and Future Plans

2.24 Chiesi Farmaceutici SpA

2.24.1 Chiesi Farmaceutici SpA Details

2.24.2 Chiesi Farmaceutici SpA Major Business

2.24.3 Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Product and Solutions

2.24.4 Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.24.5 Chiesi Farmaceutici SpA Recent Developments and Future Plans

2.25 Chong Kun Dang Pharmaceutical Corp

2.25.1 Chong Kun Dang Pharmaceutical Corp Details

2.25.2 Chong Kun Dang Pharmaceutical Corp Major Business

2.25.3 Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Product and Solutions

2.25.4 Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.25.5 Chong Kun Dang Pharmaceutical Corp Recent Developments and Future Plans

2.26 Chugai Pharmaceutical Co Ltd

2.26.1 Chugai Pharmaceutical Co Ltd Details

2.26.2 Chugai Pharmaceutical Co Ltd Major Business

2.26.3 Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Product and Solutions

2.26.4 Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.26.5 Chugai Pharmaceutical Co Ltd Recent Developments and Future Plans

2.27 CJ HealthCare Corp

2.27.1 CJ HealthCare Corp Details

2.27.2 CJ HealthCare Corp Major Business

2.27.3 CJ HealthCare Corp Blood Pressure Disorders Drug Product and Solutions

2.27.4 CJ HealthCare Corp Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.27.5 CJ HealthCare Corp Recent Developments and Future Plans

2.28 Complexa Inc

2.28.1 Complexa Inc Details

2.28.2 Complexa Inc Major Business

2.28.3 Complexa Inc Blood Pressure Disorders Drug Product and Solutions

2.28.4 Complexa Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.28.5 Complexa Inc Recent Developments and Future Plans

2.29 Corion Biotech Srl

2.29.1 Corion Biotech Srl Details

2.29.2 Corion Biotech Srl Major Business

2.29.3 Corion Biotech Srl Blood Pressure Disorders Drug Product and Solutions

2.29.4 Corion Biotech Srl Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2019-2021)

2.29.5 Corion Biotech Srl Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Blood Pressure Disorders Drug Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Blood Pressure Disorders Drug Players Market Share

3.2.2 Top 10 Blood Pressure Disorders Drug Players Market Share

3.2.3 Market Competition Trend

3.3 Blood Pressure Disorders Drug Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Blood Pressure Disorders Drug Revenue and Market Share by Type (2016-2021)

4.2 Global Blood Pressure Disorders Drug Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Blood Pressure Disorders Drug Revenue Market Share by Application (2016-2021)

5.2 Blood Pressure Disorders Drug Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Blood Pressure Disorders Drug Revenue by Type (2016-2026)

6.2 North America Blood Pressure Disorders Drug Revenue by Application (2016-2026)

6.3 North America Blood Pressure Disorders Drug Market Size by Country

6.3.1 North America Blood Pressure Disorders Drug Revenue by Country (2016-2026)

6.3.2 United States Blood Pressure Disorders Drug Market Size and Forecast (2016-2026)

6.3.3 Canada Blood Pressure Disorders Drug Market Size and Forecast (2016-2026)

6.3.4 Mexico Blood Pressure Disorders Drug Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Blood Pressure Disorders Drug Revenue by Type (2016-2026)

7.2 Europe Blood Pressure Disorders Drug Revenue by Application (2016-2026)

7.3 Europe Blood Pressure Disorders Drug Market Size by Country

7.3.1 Europe Blood Pressure Disorders Drug Revenue by Country (2016-2026)

7.3.2 Germany Blood Pressure Disorders Drug Market Size and Forecast (2016-2026)

7.3.3 France Blood Pressure Disorders Drug Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Blood Pressure Disorders Drug Market Size and Forecast (2016-2026)

7.3.5 Russia Blood Pressure Disorders Drug Market Size and Forecast (2016-2026)

7.3.6 Italy Blood Pressure Disorders Drug Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Blood Pressure Disorders Drug Revenue by Type (2016-2026)

8.2 Asia-Pacific Blood Pressure Disorders Drug Revenue by Application (2016-2026)

8.3 Asia-Pacific Blood Pressure Disorders Drug Market Size by Region

8.3.1 Asia-Pacific Blood Pressure Disorders Drug Revenue by Region (2016-2026)

8.3.2 China Blood Pressure Disorders Drug Market Size and Forecast (2016-2026)

8.3.3 Japan Blood Pressure Disorders Drug Market Size and Forecast (2016-2026)

8.3.4 South Korea Blood Pressure Disorders Drug Market Size and Forecast (2016-2026)

8.3.5 India Blood Pressure Disorders Drug Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Blood Pressure Disorders Drug Market Size and Forecast (2016-2026)

8.3.7 Australia Blood Pressure Disorders Drug Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Blood Pressure Disorders Drug Revenue by Type (2016-2026)

9.2 South America Blood Pressure Disorders Drug Revenue by Application (2016-2026)

9.3 South America Blood Pressure Disorders Drug Market Size by Country

9.3.1 South America Blood Pressure Disorders Drug Revenue by Country (2016-2026)

9.3.2 Brazil Blood Pressure Disorders Drug Market Size and Forecast (2016-2026)

9.3.3 Argentina Blood Pressure Disorders Drug Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Blood Pressure Disorders Drug Revenue by Type (2016-2026)

10.2 Middle East & Africa Blood Pressure Disorders Drug Revenue by Application (2016-2026)

10.3 Middle East & Africa Blood Pressure Disorders Drug Market Size by Country

10.3.1 Middle East & Africa Blood Pressure Disorders Drug Revenue by Country (2016-2026)

10.3.2 Turkey Blood Pressure Disorders Drug Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Blood Pressure Disorders Drug Market Size and Forecast (2016-2026)

10.3.4 UAE Blood Pressure Disorders Drug Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Blood Pressure Disorders Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Blood Pressure Disorders Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Blood Pressure Disorders Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Blood Pressure Disorders Drug Revenue (USD Million) by Region (2016-2021)

Table 5. Global Blood Pressure Disorders Drug Revenue Market Share by Region (2021-2026)

Table 6. A1M Pharma AB Corporate Information, Head Office, and Major Competitors

Table 7. A1M Pharma AB Major Business

Table 8. A1M Pharma AB Blood Pressure Disorders Drug Product and Solutions

Table 9. A1M Pharma AB Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Acceleron Pharma Inc Corporate Information, Head Office, and Major Competitors

Table 11. Acceleron Pharma Inc Major Business

Table 12. Acceleron Pharma Inc Blood Pressure Disorders Drug Product and Solutions

Table 13. Acceleron Pharma Inc Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Ache Laboratorios Farmaceuticos SA Corporate Information, Head Office, and Major Competitors

Table 15. Ache Laboratorios Farmaceuticos SA Major Business

Table 16. Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Product and Solutions

Table 17. Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Actelion Pharmaceuticals Ltd Corporate Information, Head Office, and Major Competitors

Table 19. Actelion Pharmaceuticals Ltd Major Business

Table 20. Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Product and Solutions

Table 21. Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Aerogen Ltd Corporate Information, Head Office, and Major Competitors

Table 23. Aerogen Ltd Major Business

Table 24. Aerogen Ltd Blood Pressure Disorders Drug Product and Solutions

Table 25. Aerogen Ltd Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Anavex Life Sciences Corp Corporate Information, Head Office, and Major Competitors

Table 27. Anavex Life Sciences Corp Major Business

Table 28. Anavex Life Sciences Corp Blood Pressure Disorders Drug Product and Solutions

Table 29. Anavex Life Sciences Corp Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. AnGes Inc Corporate Information, Head Office, and Major Competitors

Table 31. AnGes Inc Major Business

Table 32. AnGes Inc Blood Pressure Disorders Drug Product and Solutions

Table 33. AnGes Inc Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Arena Pharmaceuticals Inc Corporate Information, Head Office, and Major Competitors

Table 35. Arena Pharmaceuticals Inc Major Business

Table 36. Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Product and Solutions

Table 37. Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Ascendia Pharmaceuticals LLC Corporate Information, Head Office, and Major Competitors

Table 39. Ascendia Pharmaceuticals LLC Major Business

Table 40. Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Product and Solutions

Table 41. Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Ascendis Pharma A/S Corporate Information, Head Office, and Major Competitors

Table 43. Ascendis Pharma A/S Major Business

Table 44. Ascendis Pharma A/S Blood Pressure Disorders Drug Product and Solutions

Table 45. Ascendis Pharma A/S Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. AVEO Pharmaceuticals Inc Corporate Information, Head Office, and Major Competitors

Table 47. AVEO Pharmaceuticals Inc Major Business

Table 48. AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Product and Solutions

Table 49. AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Bayer AG Corporate Information, Head Office, and Major Competitors

Table 51. Bayer AG Major Business

Table 52. Bayer AG Blood Pressure Disorders Drug Product and Solutions

Table 53. Bayer AG Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Bial - Portela & Ca SA Corporate Information, Head Office, and Major Competitors

Table 55. Bial - Portela & Ca SA Major Business

Table 56. Bial - Portela & Ca SA Blood Pressure Disorders Drug Product and Solutions

Table 57. Bial - Portela & Ca SA Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Bioblue Technologies Inc Corporate Information, Head Office, and Major Competitors

Table 59. Bioblue Technologies Inc Major Business

Table 60. Bioblue Technologies Inc Blood Pressure Disorders Drug Product and Solutions

Table 61. Bioblue Technologies Inc Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Biogen Inc Corporate Information, Head Office, and Major Competitors

Table 63. Biogen Inc Major Business

Table 64. Biogen Inc Blood Pressure Disorders Drug Product and Solutions

Table 65. Biogen Inc Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Biolab Farmaceutica Ltda Corporate Information, Head Office, and Major Competitors

Table 67. Biolab Farmaceutica Ltda Major Business

Table 68. Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Product and Solutions

Table 69. Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. BioRestorative Therapies Inc Corporate Information, Head Office, and Major Competitors

Table 71. BioRestorative Therapies Inc Major Business

Table 72. BioRestorative Therapies Inc Blood Pressure Disorders Drug Product and Solutions

Table 73. BioRestorative Therapies Inc Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Boryung Pharmaceutical Co Ltd Corporate Information, Head Office, and Major Competitors

Table 75. Boryung Pharmaceutical Co Ltd Major Business

Table 76. Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Product and Solutions

Table 77. Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Bristol-Myers Squibb Co Corporate Information, Head Office, and Major Competitors

Table 79. Bristol-Myers Squibb Co Major Business

Table 80. Bristol-Myers Squibb Co Blood Pressure Disorders Drug Product and Solutions

Table 81. Bristol-Myers Squibb Co Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. Camurus AB Corporate Information, Head Office, and Major Competitors

Table 83. Camurus AB Major Business

Table 84. Camurus AB Blood Pressure Disorders Drug Product and Solutions

Table 85. Camurus AB Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Capricor Therapeutics Inc Corporate Information, Head Office, and Major Competitors

Table 87. Capricor Therapeutics Inc Major Business

Table 88. Capricor Therapeutics Inc Blood Pressure Disorders Drug Product and Solutions

Table 89. Capricor Therapeutics Inc Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 90. Celsion Corp Corporate Information, Head Office, and Major Competitors

Table 91. Celsion Corp Major Business

Table 92. Celsion Corp Blood Pressure Disorders Drug Product and Solutions

Table 93. Celsion Corp Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 94. Celtaxsys Inc Corporate Information, Head Office, and Major Competitors

Table 95. Celtaxsys Inc Major Business

Table 96. Celtaxsys Inc Blood Pressure Disorders Drug Product and Solutions

Table 97. Celtaxsys Inc Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 98. Chiesi Farmaceutici SpA Corporate Information, Head Office, and Major Competitors

Table 99. Chiesi Farmaceutici SpA Major Business

Table 100. Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Product and Solutions

Table 101. Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 102. Chong Kun Dang Pharmaceutical Corp Corporate Information, Head Office, and Major Competitors

Table 103. Chong Kun Dang Pharmaceutical Corp Major Business

Table 104. Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Product and Solutions

Table 105. Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 106. Chugai Pharmaceutical Co Ltd Corporate Information, Head Office, and Major Competitors

Table 107. Chugai Pharmaceutical Co Ltd Major Business

Table 108. Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Product and Solutions

Table 109. Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 110. CJ HealthCare Corp Corporate Information, Head Office, and Major Competitors

Table 111. CJ HealthCare Corp Major Business

Table 112. CJ HealthCare Corp Blood Pressure Disorders Drug Product and Solutions

Table 113. CJ HealthCare Corp Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 114. Complexa Inc Corporate Information, Head Office, and Major Competitors

Table 115. Complexa Inc Major Business

Table 116. Complexa Inc Blood Pressure Disorders Drug Product and Solutions

Table 117. Complexa Inc Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 118. Corion Biotech Srl Corporate Information, Head Office, and Major Competitors

Table 119. Corion Biotech Srl Major Business

Table 120. Corion Biotech Srl Blood Pressure Disorders Drug Product and Solutions

Table 121. Corion Biotech Srl Blood Pressure Disorders Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 122. Global Blood Pressure Disorders Drug Revenue (USD Million) by Players (2019-2021)

Table 123. Global Blood Pressure Disorders Drug Revenue Share by Players (2019-2021)

Table 124. Breakdown of Blood Pressure Disorders Drug by Company Type (Tier 1, Tier 2 and Tier 3)

Table 125. Blood Pressure Disorders Drug Players Head Office, Products and Services Provided

Table 126. Blood Pressure Disorders Drug Mergers & Acquisitions in the Past Five Years

Table 127. Blood Pressure Disorders Drug New Entrants and Expansion Plans

Table 128. Global Blood Pressure Disorders Drug Revenue (USD Million) by Type (2016-2021)

Table 129. Global Blood Pressure Disorders Drug Revenue Share by Type (2016-2021)

Table 130. Global Blood Pressure Disorders Drug Revenue Forecast by Type (2021-2026)

Table 131. Global Blood Pressure Disorders Drug Revenue by Application (2016-2021)

Table 132. Global Blood Pressure Disorders Drug Revenue Forecast by Application (2021-2026)

Table 133. North America Blood Pressure Disorders Drug Revenue by Type (2016-2021) & (USD Million)

Table 134. North America Blood Pressure Disorders Drug Revenue by Type (2021-2026) & (USD Million)

Table 135. North America Blood Pressure Disorders Drug Revenue by Application (2016-2021) & (USD Million)

Table 136. North America Blood Pressure Disorders Drug Revenue by Application (2021-2026) & (USD Million)

Table 137. North America Blood Pressure Disorders Drug Revenue by Country (2016-2021) & (USD Million)

Table 138. North America Blood Pressure Disorders Drug Revenue by Country (2021-2026) & (USD Million)

Table 139. Europe Blood Pressure Disorders Drug Revenue by Type (2016-2021) & (USD Million)

Table 140. Europe Blood Pressure Disorders Drug Revenue by Type (2021-2026) & (USD Million)

Table 141. Europe Blood Pressure Disorders Drug Revenue by Application (2016-2021) & (USD Million)

Table 142. Europe Blood Pressure Disorders Drug Revenue by Application (2021-2026) & (USD Million)

Table 143. Europe Blood Pressure Disorders Drug Revenue by Country (2016-2021) & (USD Million)

Table 144. Europe Blood Pressure Disorders Drug Revenue by Country (2021-2026) & (USD Million)

Table 145. Asia-Pacific Blood Pressure Disorders Drug Revenue by Type (2016-2021) & (USD Million)

Table 146. Asia-Pacific Blood Pressure Disorders Drug Revenue by Type (2021-2026) & (USD Million)

Table 147. Asia-Pacific Blood Pressure Disorders Drug Revenue by Application (2016-2021) & (USD Million)

Table 148. Asia-Pacific Blood Pressure Disorders Drug Revenue by Application (2021-2026) & (USD Million)

Table 149. Asia-Pacific Blood Pressure Disorders Drug Revenue by Region (2016-2021) & (USD Million)

Table 150. Asia-Pacific Blood Pressure Disorders Drug Revenue by Region (2021-2026) & (USD Million)

Table 151. South America Blood Pressure Disorders Drug Revenue by Type (2016-2021) & (USD Million)

Table 152. South America Blood Pressure Disorders Drug Revenue by Type (2021-2026) & (USD Million)

Table 153. South America Blood Pressure Disorders Drug Revenue by Application (2016-2021) & (USD Million)

Table 154. South America Blood Pressure Disorders Drug Revenue by Application (2021-2026) & (USD Million)

Table 155. South America Blood Pressure Disorders Drug Revenue by Country (2016-2021) & (USD Million)

Table 156. South America Blood Pressure Disorders Drug Revenue by Country (2021-2026) & (USD Million)

Table 157. Middle East & Africa Blood Pressure Disorders Drug Revenue by Type (2016-2021) & (USD Million)

Table 158. Middle East & Africa Blood Pressure Disorders Drug Revenue by Type (2021-2026) & (USD Million)

Table 159. Middle East & Africa Blood Pressure Disorders Drug Revenue by Application (2016-2021) & (USD Million)

Table 160. Middle East & Africa Blood Pressure Disorders Drug Revenue by Application (2021-2026) & (USD Million)

Table 161. Middle East & Africa Blood Pressure Disorders Drug Revenue by Country (2016-2021) & (USD Million)

Table 162. Middle East & Africa Blood Pressure Disorders Drug Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Blood Pressure Disorders Drug Picture

Figure 2. Global Blood Pressure Disorders Drug Revenue Market Share by Type in 2020

Figure 3. Diuretics

Figure 4. Angiotensin Converting Enzyme (ACE) Inhibitors

Figure 5. Angiotensin Receptor Blockers (ARBs)

Figure 6. Others

Figure 7. Blood Pressure Disorders Drug Revenue Market Share by Application in 2020

Figure 8. Hypertension Picture

Figure 9. Hypotension Picture

Figure 10. Pulmonary Hypertension Picture

Figure 11. Global Blood Pressure Disorders Drug Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 12. Global Blood Pressure Disorders Drug Revenue and Forecast (2016-2026) & (USD Million)

Figure 13. Global Blood Pressure Disorders Drug Revenue Market Share by Region (2016-2026)

Figure 14. Global Blood Pressure Disorders Drug Revenue Market Share by Region in 2020

Figure 15. North America Blood Pressure Disorders Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Europe Blood Pressure Disorders Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Asia-Pacific Blood Pressure Disorders Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. South America Blood Pressure Disorders Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Middle East and Africa Blood Pressure Disorders Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Blood Pressure Disorders Drug Market Drivers

Figure 21. Blood Pressure Disorders Drug Market Restraints

Figure 22. Blood Pressure Disorders Drug Market Trends

Figure 23. A1M Pharma AB Recent Developments and Future Plans

Figure 24. Acceleron Pharma Inc Recent Developments and Future Plans

Figure 25. Ache Laboratorios Farmaceuticos SA Recent Developments and Future Plans

Figure 26. Actelion Pharmaceuticals Ltd Recent Developments and Future Plans

Figure 27. Aerogen Ltd Recent Developments and Future Plans

Figure 28. Anavex Life Sciences Corp Recent Developments and Future Plans

Figure 29. AnGes Inc Recent Developments and Future Plans

Figure 30. Arena Pharmaceuticals Inc Recent Developments and Future Plans

Figure 31. Ascendia Pharmaceuticals LLC Recent Developments and Future Plans

Figure 32. Ascendis Pharma A/S Recent Developments and Future Plans

Figure 33. AVEO Pharmaceuticals Inc Recent Developments and Future Plans

Figure 34. Bayer AG Recent Developments and Future Plans

Figure 35. Bial - Portela & Ca SA Recent Developments and Future Plans

Figure 36. Bioblue Technologies Inc Recent Developments and Future Plans

Figure 37. Biogen Inc Recent Developments and Future Plans

Figure 38. Biolab Farmaceutica Ltda Recent Developments and Future Plans

Figure 39. BioRestorative Therapies Inc Recent Developments and Future Plans

Figure 40. Boryung Pharmaceutical Co Ltd Recent Developments and Future Plans

Figure 41. Bristol-Myers Squibb Co Recent Developments and Future Plans

Figure 42. Camurus AB Recent Developments and Future Plans

Figure 43. Capricor Therapeutics Inc Recent Developments and Future Plans

Figure 44. Celsion Corp Recent Developments and Future Plans

Figure 45. Celtaxsys Inc Recent Developments and Future Plans

Figure 46. Chiesi Farmaceutici SpA Recent Developments and Future Plans

Figure 47. Chong Kun Dang Pharmaceutical Corp Recent Developments and Future Plans

Figure 48. Chugai Pharmaceutical Co Ltd Recent Developments and Future Plans

Figure 49. CJ HealthCare Corp Recent Developments and Future Plans

Figure 50. Complexa Inc Recent Developments and Future Plans

Figure 51. Corion Biotech Srl Recent Developments and Future Plans

Figure 52. Global Blood Pressure Disorders Drug Revenue Share by Players in 2020

Figure 53. Blood Pressure Disorders Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 54. Global Top 3 Players Blood Pressure Disorders Drug Revenue Market Share in 2020

Figure 55. Global Top 10 Players Blood Pressure Disorders Drug Revenue Market Share in 2020

Figure 56. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 57. Global Blood Pressure Disorders Drug Revenue Share by Type in 2020

Figure 58. Global Blood Pressure Disorders Drug Market Share Forecast by Type (2021-2026)

Figure 59. Global Blood Pressure Disorders Drug Revenue Share by Application in 2020

Figure 60. Global Blood Pressure Disorders Drug Market Share Forecast by Application (2021-2026)

Figure 61. North America Blood Pressure Disorders Drug Sales Market Share by Type (2016-2026)

Figure 62. North America Blood Pressure Disorders Drug Sales Market Share by Application (2016-2026)

Figure 63. North America Blood Pressure Disorders Drug Revenue Market Share by Country (2016-2026)

Figure 64. United States Blood Pressure Disorders Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Canada Blood Pressure Disorders Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Mexico Blood Pressure Disorders Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Europe Blood Pressure Disorders Drug Sales Market Share by Type (2016-2026)

Figure 68. Europe Blood Pressure Disorders Drug Sales Market Share by Application (2016-2026)

Figure 69. Europe Blood Pressure Disorders Drug Revenue Market Share by Country (2016-2026)

Figure 70. Germany Blood Pressure Disorders Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. France Blood Pressure Disorders Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. United Kingdom Blood Pressure Disorders Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Russia Blood Pressure Disorders Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Italy Blood Pressure Disorders Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Asia-Pacific Blood Pressure Disorders Drug Sales Market Share by Type (2016-2026)

Figure 76. Asia-Pacific Blood Pressure Disorders Drug Sales Market Share by Application (2016-2026)

Figure 77. Asia-Pacific Blood Pressure Disorders Drug Revenue Market Share by Region (2016-2026)

Figure 78. China Blood Pressure Disorders Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Japan Blood Pressure Disorders Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. South Korea Blood Pressure Disorders Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. India Blood Pressure Disorders Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Southeast Asia Blood Pressure Disorders Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. Australia Blood Pressure Disorders Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. South America Blood Pressure Disorders Drug Sales Market Share by Type (2016-2026)

Figure 85. South America Blood Pressure Disorders Drug Sales Market Share by Application (2016-2026)

Figure 86. South America Blood Pressure Disorders Drug Revenue Market Share by Country (2016-2026)

Figure 87. Brazil Blood Pressure Disorders Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 88. Argentina Blood Pressure Disorders Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 89. Middle East and Africa Blood Pressure Disorders Drug Sales Market Share by Type (2016-2026)

Figure 90. Middle East and Africa Blood Pressure Disorders Drug Sales Market Share by Application (2016-2026)

Figure 91. Middle East and Africa Blood Pressure Disorders Drug Revenue Market Share by Country (2016-2026)

Figure 92. Turkey Blood Pressure Disorders Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 93. Saudi Arabia Blood Pressure Disorders Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 94. UAE Blood Pressure Disorders Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 95. Methodology

Figure 96. Research Process and Data Source

Sample Request is not available